tiprankstipranks
Geron price target raised to $5 from $4 at Needham
PremiumThe FlyGeron price target raised to $5 from $4 at Needham
2M ago
Geron reports FDA advisors vote in favor of benefit/risk of imetelstat
PremiumThe Fly
Geron reports FDA advisors vote in favor of benefit/risk of imetelstat
2M ago
FDA Oncologic Drugs Advisory Committee holds virtual meeting
PremiumThe Fly
FDA Oncologic Drugs Advisory Committee holds virtual meeting
2M ago
FDA Oncologic Drugs Advisory Committee holds virtual meeting
PremiumThe FlyFDA Oncologic Drugs Advisory Committee holds virtual meeting
2M ago
Needham biotechnology analyst to hold an analyst/industry conference call
PremiumThe Fly
Needham biotechnology analyst to hold an analyst/industry conference call
2M ago
Geron price target lowered to $4.50 from $5 at Baird
PremiumThe Fly
Geron price target lowered to $4.50 from $5 at Baird
2M ago
Unusually active option classes on open February 12th
PremiumThe FlyUnusually active option classes on open February 12th
3M ago
Geron’s Imetelstat NDA Accepted by FDA for Anemia Treatment
PremiumCompany Announcements
Geron’s Imetelstat NDA Accepted by FDA for Anemia Treatment
3M ago
Oppenheimer, Wedbush say buy these biotech stocks for 2024
PremiumThe Fly
Oppenheimer, Wedbush say buy these biotech stocks for 2024
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100